Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RALLY-IBD
NCT07368972Phase 2Recruiting
- Sponsor
- Disc Medicine
- Start
- Feb 2026
- Primary completion
- Oct 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of selcodebart in anemia of inflammation (AI), sponsored by Disc Medicine. Started Feb 2026; status: recruiting.
02
Drugs
selcodebart
03
Conditions
anemia of inflammation (AI)
Beyond the preview
Go deeper on NCT07368972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07368972.